Research Square (Research Square),
Год журнала:
2022,
Номер
unknown
Опубликована: Фев. 24, 2022
Abstract
Background.
UBASH3A
as
a
negative
regulator
of
T-cell
receptors
(TCRs)
signaling
is
susceptible
factor
for
rheumatoid
arthritis
(RA)
patients
who
exhibit
immune
dysfunction.
We
studied
expression
in
CD4
+
T
cells
from
healthy
donors
and
RA
patients,
the
involvement
super-enhancer
(SE)
control
expression,
contribution
to
proinflammatory
cytokine
production.
Methods.
The
mRNA
protein
levels
were
examined
by
quantitative
PCR
Western
blotting,
respectively.
Locked
nucleic
acid
was
administered
inhibit
enhancer
RNA
(eRNA)
expression.
Factors
recruited
loci
displaying
SE
architecture
chromatin
immunoprecipitation.
transfected
with
plasmids,
measured
cytometric
bead
array.
Results.
lower
than
those
donors.
reduced
eRNA_1
eRNA_3
knockdown.
In
BTB
CNC
homology
2
(BACH2),
silencing
transcription
factor,
accumulated
at
cells,
whereas
SE-defining
mediator
complex
subunit
1
(MED1)/bromodomain
4
(BRD4),
did
not.
However,
opposite
phenomena
observed
Although
stimulation
TCRs
expressed
on
led
interleukin
(IL)-6
production,
over-expression
significantly
inhibited
its
Conclusions.
Transcription
suppressed
via
epigenetic
regulation
patients.
Decreased
lead
excessive
activation
TCR
signaling,
resulting
enhanced
production
IL-6.
Frontiers in Immunology,
Год журнала:
2025,
Номер
15
Опубликована: Янв. 6, 2025
Systemic
lupus
erythematosus
(SLE)
is
a
chronic
autoimmune
disease.
The
inconsistent
prevalence
of
SLE
between
monozygotic
twins
suggests
that
environmental
factors
affect
the
occurrence
this
Abnormal
epigenetic
regulation
strongly
associated
with
pathogenesis
SLE.
Epigenetic
mechanisms
may
be
involved
in
development
through
DNA
methylation,
histone
modification,
noncoding
RNAs,
and
other
modifications.
This
review
aims
to
show
numerous
studies
as
treasure
map
better
understand
effects
aberrant
modification
onset
SLE,
which
will
benefit
current
basic
research
provide
potential
diagnostic
biomarkers
or
therapeutic
targets
for
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Сен. 12, 2023
Systemic
lupus
erythematosus
(SLE)
is
a
heterogeneous
multisystem
inflammatory
disease
with
wide
variability
in
clinical
manifestations.
Natural
arising
CD4+
regulatory
T
cells
(Tregs)
play
critical
role
maintaining
peripheral
tolerance
by
suppressing
inflammation
and
preventing
autoimmune
responses
SLE.
Additionally,
CD8+
cells,
type
1
(Tr1),
B
also
have
less
well-defined
the
pathogenesis
of
Elucidation
roles
various
Treg
subsets
dedicated
to
immune
homeostasis
will
provide
novel
therapeutic
approach
that
governs
for
remission
active
lupus.
Diminished
interleukin
(IL)-2
production
associated
depleted
cell
population,
its
reversibility
IL-2
therapy
provides
important
reasons
treatment
This
review
focuses
on
new
therapeutics
human
low-dose
benefits
Abstract
CD4
+
CD25
regulatory
T
cells
(Tregs),
a
subpopulation
of
naturally
that
characteristically
express
transcription
factor
Forkhead
box
P3
(FOXP3),
play
pivotal
role
in
the
maintenance
immune
homeostasis
and
prevention
autoimmunity.
With
development
biological
technology,
understanding
plasticity
stability
Tregs
has
been
further
developed.
Recent
studies
have
suggested
human
are
functionally
phenotypically
diverse.
The
functions
mechanisms
different
phenotypes
disease
settings,
such
as
tumor
microenvironment,
autoimmune
diseases,
transplantation,
gradually
become
hot
spots
immunology
research
arouse
extensive
attention.
Among
complex
functions,
FOXP3
possess
potent
immunosuppressive
capacity
can
produce
various
cytokines,
IL‐2,
IL‐10,
TGF‐β,
to
regulate
homeostasis.
They
alleviate
progression
diseases
by
resisting
inflammatory
responses,
whereas
promoting
poor
prognosis
helping
evade
surveillance
or
suppressing
effector
activity.
Therefore,
methods
for
targeting
their
depleting
them
strengthen
immunity
expanding
treat
immunological
need
be
Here,
we
discuss
subpopulations
essential
immunotherapeutic
strategies
involving
diseases.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(7), С. 3145 - 3145
Опубликована: Март 28, 2025
Metabolic
syndrome
(MetS)
associated
with
Osteoarthritis
(OA)
is
an
increasingly
recognised
entity.
Whilst
the
degenerative
pattern
in
cuff-tear
arthropathy
(CTA)
has
been
well
documented,
biological
processes
behind
primary
shoulder
OA
and
CTA
remain
less
understood.
This
study
investigates
transcriptomic
differences
these
conditions,
alongside
impact
of
MetS
patients
undergoing
total
replacement.
In
a
multi-centre
study,
20
replacement
were
included
based
on
specific
treatment
indications
for
as
25
rotator
cuff
repair
(RCR)
comparator
group.
Tissues
from
subchondral
bone,
capsule
(OA
RCR),
synovium
biopsied,
RNA
sequencing
was
performed
using
Illumina
platforms.
Differential
gene
expression
conducted
DESeq2,
adjusting
demographic
factors,
followed
by
pathway
enrichment
mitch
package.
Gene
expressions
differentially
affected.
showed
mitochondrial
dysfunction,
GATD3A
downregulation,
increased
cartilage
degradation,
while
marked
upregulated
inflammatory
catabolic
pathways.
The
effect
pathologies
further
shown.
disrupted
WNT/β-catenin
signalling
CTA,
OA.
Genes
such
ACAN,
PANX3,
CLU,
VAT1L
upregulated,
highlighting
potential
biomarkers
early
detection.
analysis
reveals
key
between
end-stage
glenohumeral
shows
heightened
metabolic/protein
synthesis
activity
immune-driven
inflammation.
Under
MetS,
dysfunction
(including
downregulation)
altered
Wnt/β-catenin
intensify
bone
damage.
contrast,
features
strong
complement
activation,
expression,
collagen
remodelling.
worsens
both
conditions
via
oxidative
stress,
advanced
glycation
end
products,
ECM
disruption—particularly,
CS/DS
degradation.
These
distinctions
support
targeted
treatments,
antioxidants
Wnt
modulators
to
aggrecanase
inhibitors
or
clusterin
augmentation.
Addressing
molecular
disruptions,
especially
those
amplified
may
preserve
function,
delay
surgical
intervention,
improve
long-term
patient
outcomes.
Clinical and Translational Medicine,
Год журнала:
2022,
Номер
12(12)
Опубликована: Ноя. 29, 2022
The
aberrant
differentiation
of
T
follicular
helper
(Tfh)
cells
plays
an
important
role
in
the
pathogenesis
systemic
lupus
erythematosus
(SLE).
However,
mechanism
regulating
Tfh
remains
unclear.
Long
noncoding
RNAs
(lncRNAs)
act
as
regulators
processes
innate
and
adaptive
immune
response.
Whether
lncRNAs
are
involved
cell
autoimmune
responses
need
to
be
further
identified.The
characters
functions
human
IL21-AS1
its
mouse
homologous
lncRNA
(mIl21-AS)
were
investigated
by
a
series
biochemical
assays
transfection
assay.
mIl21-AS1
humoral
response
vivo
was
explored
keyhole
limpet
haemocyanin
(KLH)
chronic
graft
versus
host
disease
(cGVHD)
model.Human
identified
cloned.
We
uncovered
that
highly
expressed
CD4+
SLE
patients
cells,
which
promoted
cells.
Mechanistically,
bound
heterogeneous
nuclear
ribonucleoprotein
U
recruited
acetyltransferases
CREB-binding
protein
promoter
IL21,
leading
transcriptional
activation
IL21
through
increasing
Histone
H3
acetylation
level
on
promoter.
Moreover,
proportion
antibodies
production
significantly
increased
mIl21-AS
knock-in
mice
immunized
with
KLH.
overexpression
also
exacerbated
lupus-like
phenotype
cGVHD
model.Our
results
demonstrate
activates
transcription
via
epigenetic
promote
germinal
centre
response,
adding
insight
into
molecular
regulation
providing
novel
target
for
treatment.
Biomolecules,
Год журнала:
2023,
Номер
13(6), С. 960 - 960
Опубликована: Июнь 8, 2023
The
treatment
of
rheumatoid
arthritis
was
revolutionized
with
the
use
molecular-targeted
drugs
that
target
immunoregulatory
molecules.
success
these
prompted
development
for
systemic
lupus
erythematosus.
However,
erythematosus
is
a
disease
high
heterogeneous
immune
abnormalities,
and
diverse
cells
or
molecules
can
be
targets.
Thus,
identification
subpopulations
based
on
abnormalities
essential
effective
treatment.
One
analytical
method
used
to
identify
immunophenotyping
peripheral
blood
samples
patients.
This
analysis
evaluates
validity
cell
subsets,
which
are
expected
developed
as
biomarkers
precision
medicine
in
appropriate
targets
set
each
subpopulation.
Inflammation and Regeneration,
Год журнала:
2022,
Номер
42(1)
Опубликована: Ноя. 3, 2022
Rheumatoid
arthritis
(RA)
is
associated
with
immune
dysfunction.
UBASH3A
as
a
negative
regulator
of
T
cell
receptors
(TCRs)
signaling
susceptible
factor
in
RA.
The
aim
this
study
was
to
determine
the
role
RA
pathogenesis,
by
assessing
super-enhancer
(SE)
control
expression
CD4+
cells
and
contribution
latter
proinflammatory
cytokine
production
patients
RA.UBASH3A
mRNA
protein
levels
were
quantified
PCR
western
blotting,
respectively.
treated
locked
nucleic
acid
inhibit
enhancer
RNA
(eRNA)
expression.
Chromatin
immunoprecipitation
used
identify
factors
recruited
loci
displaying
SE
architecture.
transfected
plasmids,
measured
cytometric
bead
array.UBASH3A
extracted
susceptibility
gene
SNPs
SEs
that
are
highly
expressed
silico
screening.
lower
than
control.
eRNA_1
eRNA_3
knockdown
reduced
levels.
exhibited
accumulation
BTB
CNC
homology
2
(BACH2),
silencing
transcription
factor,
at
cells,
but
not
SE-defining
mediator
complex
subunit
1
(MED1)/bromodomain
4
(BRD4).
However,
opposite
changes
observed
Stimulation
TCRs
on
resulted
interleukin
(IL)-6
production,
while
over-expression
significantly
inhibited
production.In
RA,
suppressed
via
epigenetic
regulation
cells.
Low
result
excessive
TCR
signal
activation
subsequent
enhancement
IL-6
production.
Scandinavian Journal of Immunology,
Год журнала:
2022,
Номер
95(6)
Опубликована: Март 22, 2022
Systemic
lupus
erythematosus
(SLE)
is
a
remarkable
heterogeneous
autoimmune
disease
that
sometimes
hard
to
diagnose
at
the
early
stage
and
can
lead
premature
mortality.
Long
non-coding
RNAs
(lncRNAs)
are
class
of
non-protein-coding
greater
than
200
nucleotides
in
length
regulate
gene
expression
various
human
diseases,
including
SLE.
Peripheral
blood
samples
renal
tissue
from
SLE
patients
were
used
for
study.
Abnormally
expressed
lncRNAs
have
been
shown
influence
several
signalling
pathways,
IFN-I,
MAPK
WNT
pathways.
This
affect
cellular
phenotypes
like
cell
activation,
differentiation
skewing,
cytokine
production
apoptosis.
Many
reported
may
be
useful
diagnosing,
evaluating
progression
predicting
potential
organ
damage
patients.
While
numerous
play
important
roles
SLE,
more
basic
clinical
studies
warranted
clarify
function
these
regulatory
molecules
determine
their
diagnostic
value.